Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma

标题
Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 26, Pages 4371-4377
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2009-07-28
DOI
10.1200/jco.2008.21.3017

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now